Feasibility trial to assess Attention Deficit Hyperactivity Disorder (ADHD) in the Criminal Justice System by using QbTest (a computer task)

Using an objective computer task (QbTest) to aid the identification of Attention Deficit Hyperactivity Disorder (ADHD) in young people in the criminal justice secure estate: a feasibility randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17402196

Enrollment

Registered

2019-02-08

Start date

2019-02-11

Completion date

Unknown

Last updated

2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Learning disorders - ADHD Mental and Behavioural Disorders

Interventions

QbTest (QbTech Ltd) is a computer task that measures three core aspects of ADHD: attention, impulsivity and motor activity. Performance on the task provides information (via an immediate report) on th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Young people at HMPYOI Wetherby identified as presenting with ADHD symptoms via the CHAT e.g. any CHAT ADHD symptom read codes via SystmOne

Exclusion criteria

Exclusion criteria: 1. On remand (uncertain/sudden release) 2. Non English speaking 3. Previous or current confirmed diagnosis of ADHD 4. Currently receiving ADHD medication 5. Deemed to present too high a risk to either the researcher or the staff 6. Unable to provide informed consent (over 16) 7. Parental/legal guardian consent not received (under 16)

Design outcomes

Primary

Measure	Time frame
1. Eligibility rate recorded as the number of eligible young people against the total number of young people identified with ADHD needs 2. Recruitment rate recorded as the number of eligible young people who consent to participate 3. Acceptability of randomisation recorded as the number of young people randomised 4. Attrition rate recorded as the number of young people who consent to participate that remain in the study until the end of follow up at 6 months	—

Measure

Time frame

1. Eligibility rate recorded as the number of eligible young people against the total number of young people identified with ADHD needs 2. Recruitment rate recorded as the number of eligible young people who consent to participate 3. Acceptability of randomisation recorded as the number of young people randomised 4. Attrition rate recorded as the number of young people who consent to participate that remain in the study until the end of follow up at 6 months

—

Secondary

Measure	Time frame
1. Behaviour is measured using the Strengths and Difficulties Questionnaire (SDQ) at baseline, 3 and 6 months 2. ADHD symptoms are measured using the Barkley ADHD Rating Scale- IV Brief Screen (BAARS-IV Brief Screen) at baseline, 3 and 6 months 3. Health-related quality of life is measured using the Child Health Utility Instrument (CHU-9D) at baseline, 3 and 6 months 4. Objective rating of symptoms and functioning is measured by the Swanson, Nolan and Pelham Questionnaire (SNAP-IV) and Children's Global Assessment Scale (C-GAS) at baseline, 3 and 6 months 5. Number and duration of (in minutes) consultations/appointments until confirmed ADHD diagnosis as recorded on a pro-forma completed by clinicians after each consultation with the young person 6. Number of days until a confirmed diagnosis is reached using file information 7. Contact with services is measured using the modified Client Service Receipt Inventory (CSRI) ) at baseline, 3 and 6 months 8. Number of reordered behavioural incidents and adjudications are collecting using prison file information at baseline, 3 and 6 months	—

Measure

Time frame

1. Behaviour is measured using the Strengths and Difficulties Questionnaire (SDQ) at baseline, 3 and 6 months 2. ADHD symptoms are measured using the Barkley ADHD Rating Scale- IV Brief Screen (BAARS-IV Brief Screen) at baseline, 3 and 6 months 3. Health-related quality of life is measured using the Child Health Utility Instrument (CHU-9D) at baseline, 3 and 6 months 4. Objective rating of symptoms and functioning is measured by the Swanson, Nolan and Pelham Questionnaire (SNAP-IV) and Children's Global Assessment Scale (C-GAS) at baseline, 3 and 6 months 5. Number and duration of (in minutes) consultations/appointments until confirmed ADHD diagnosis as recorded on a pro-forma completed by clinicians after each consultation with the young person 6. Number of days until a confirmed diagnosis is reached using file information 7. Contact with services is measured using the modified Client Service Receipt Inventory (CSRI) ) at baseline, 3 and 6 months 8. Number of reordered behavioural incidents and adjudications are collecting using prison file information at baseline, 3 and 6 months

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026